[144] Revolution Medicines, Inc. SEC Filing
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Registrant: A Form 144 notice filed in connection with proposed sale of 3,120 shares of Common Stock by an issuer-related transaction dated 04/27/2026. The filing also discloses prior Rule 10b5-1 sales of 37,450 shares on 03/25/2026 for $3,578,821.24.
Positive
- None.
Negative
- None.
Key Figures
Planned sale (April): 3,120 shares
10b5-1 sale (prior): 37,450 shares
Proceeds recorded: $3,578,821.24
+1 more
4 metrics
Planned sale (April)
3,120 shares
Exercise of stock options by issuer on 04/27/2026
10b5-1 sale (prior)
37,450 shares
Sale by Anthony Mancini on 03/25/2026
Proceeds recorded
$3,578,821.24
Proceeds from 10b5-1 sale on 03/25/2026
Form type
Form 144
Notice of proposed sale under Rule 144
Key Terms
Form 144, 10b5-1, Exercise of Stock Options
3 terms
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"10b5-1 Sales for ANTHONY MANCINI 700 Saginaw Drive"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold | Exercise of Stock Options"